Acute promyelocytic leukemia surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{Acute promyelocytic leukemia}} | {{Acute promyelocytic leukemia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{S.G.}} | ||
==Overview== | ==Overview== | ||
Latest revision as of 17:44, 24 January 2019
|
Acute promyelocytic leukemia Microchapters |
|
Differentiating Acute promyelocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute promyelocytic leukemia surgery On the Web |
|
American Roentgen Ray Society Images of Acute promyelocytic leukemia surgery |
|
Directions to Hospitals Treating Acute promyelocytic leukemia |
|
Risk calculators and risk factors for Acute promyelocytic leukemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Surgical intervention is not recommended for the management of acute promyelocytic leukemia.
Indications
- Surgical intervention is not recommended for the management of acute promyelocytic leukemia.[1]
Surgery
- Surgical intervention is not recommended for the management of acute promyelocytic leukemia.[1]
References
- ↑ 1.0 1.1 Huang J, Sun M, Wang Z, Zhang Q, Lou J, Cai Y, Chen W, Du X (November 2016). "Induction treatments for acute promyelocytic leukemia: a network meta-analysis". Oncotarget. 7 (44): 71974–71986. doi:10.18632/oncotarget.12451. PMC 5342137. PMID 27713127.